28 de abril de 2015 / 7:29 / en 2 años

BRIEF-Mabion to sell MabionCD20 medicine in Brazil

April 28 (Reuters) - Mabion SA :

* Signs a letter of intent with Biolotus Biotech concerning cooperation on registration and sales of MabionCD20 medicine in Brazil Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below